Zacks Research Has Strong Forecast for ESPR FY2027 Earnings
Esperion Therapeutics, Inc. (NASDAQ:ESPR – Free Report) – Equities research analysts at Zacks Research increased their FY2027 EPS estimates for shares of Esperion Therapeutics in a report released on Monday, April 28th. Zacks Research analyst K. Das now forecasts that the biopharmaceutical company will post earnings of $0.09 per share for the year, up from […]
Esperion Therapeutics, Inc. (NASDAQ:ESPR – Free Report) – Equities research analysts at Zacks Research increased their FY2027 EPS estimates for shares of Esperion Therapeutics in a report released on Monday, April 28th. Zacks Research analyst K. Das now forecasts that the biopharmaceutical company will post earnings of $0.09 per share for the year, up from […]
